Additionally, an immunohistochemical study of highly differentiated, non-metastatic and Oct4-negative ccRCC revealed high CD133 expression, suggesting that it is a favorable prognostic marker [83]. This evidence concerns the gene PROM1 and nonpapillary renal cell carcinoma.